Sign in

CIK 0001723128 · Large accelerated filer

Amneal Pharmaceuticals, Inc.

Sign in to watch
Ticker
AMRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
Phone
(908) 947-3120
Former names
Atlas Holdings, Inc.
  1. SC 13D/A Stake Beneficial Ownership Report
  2. 25-NSE Other Notification of Removal from Listing
  3. 8-K12B Other 8-K12B
  4. 8-K Event Results of operations · Regulation FD disclosure
  5. 8-K Event Results of operations · Regulation FD disclosure
  6. SC 13D/A Stake Beneficial Ownership Report
  7. SC 13D/A Stake Beneficial Ownership Report
  8. SC 13D/A Stake Beneficial Ownership Report
  9. SC 13D/A Stake Beneficial Ownership Report
  10. SC 13D/A Stake Beneficial Ownership Report
  11. 8-K Event Material agreement · Regulation FD disclosure
  12. 4 Open-market sale Executive Vice President sold 29,302 shares at $4.13 ($120,921)
  13. 144/A Insider Sale of Securities
  14. 144 Insider Sale of Securities
  15. 144 Insider Sale of Securities
  16. S-8 Other Securities Offered to Employees in Benefit Plans
  17. 10-Q Report Quarterly Report
  18. 8-K Event Results of operations · Regulation FD disclosure
  19. 4 Option exercise Director acquired 54,949 shares (option exercise)
  20. 4 Shares withheld for taxes Executive Vice President gave up 11,571 shares (to pay taxes)

Page 14 of 35 · 695 filings